Insider Buy/Sell Details for the Biotechnology Industry — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1341)
Centessa Pharmaceuticals plc (CNTA)
Weinhoff Gregory M — Chief Business Officer
Shares
11,943
Price
$27.16
Total Value
$324.34K
Shares Held After
65,925
% of Holdings
15.3%
Centessa Pharmaceuticals plc (CNTA)
Weinhoff Gregory M — Chief Business Officer
Shares
61,253
Price
$26.17
Total Value
$1.60M
Shares Held After
77,868
% of Holdings
44.0%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
12,068
Price
$27.13
Total Value
$327.44K
Shares Held After
62,085
% of Holdings
16.3%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
107,961
Price
$26.15
Total Value
$2.82M
Shares Held After
74,153
% of Holdings
59.3%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
370,000
Price
$5.00
Total Value
$1.85M
Shares Held After
0
% of Holdings
100.0%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
6,187
Price
$24.99
Total Value
$154.58K
Shares Held After
657,299
% of Holdings
0.9%
Surrozen, Inc./DE (SRZN)
TCG Crossover GP II, LLC — 10% Owner
Shares
6,187
Price
$24.99
Total Value
$154.58K
Shares Held After
657,301
% of Holdings
0.9%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
300
Price
$70.15
Total Value
$21.05K
Shares Held After
4,458,447
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,815
Price
$69.29
Total Value
$402.93K
Shares Held After
4,458,747
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
13,885
Price
$68.47
Total Value
$950.69K
Shares Held After
4,464,562
% of Holdings
0.3%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
300
Price
$70.15
Total Value
$21.05K
Shares Held After
655,686
% of Holdings
0.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
5,363
Price
$69.32
Total Value
$371.75K
Shares Held After
655,986
% of Holdings
0.8%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
14,337
Price
$68.48
Total Value
$981.81K
Shares Held After
661,349
% of Holdings
2.1%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Title: Chief Technology and Manufacturing Officer
Shares
10,076
Price
$2.55
Total Value
$25.68K
Shares Held After
515,427
% of Holdings
1.9%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
7,043
Price
$2.55
Total Value
$17.95K
Shares Held After
507,261
% of Holdings
1.4%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
6,348
Price
$27.37
Total Value
$173.75K
Shares Held After
82,489
% of Holdings
7.1%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
306
Price
$99.12
Total Value
$30.33K
Shares Held After
70,708
% of Holdings
0.4%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
5,505
Price
$98.44
Total Value
$541.91K
Shares Held After
71,014
% of Holdings
7.2%
Nuvalent, Inc. (NUVL)
Pelish Henry E. — Chief Scientific Officer
Shares
24,189
Price
$97.79
Total Value
$2.37M
Shares Held After
76,519
% of Holdings
24.0%
Absci Corp (ABSI)
Busch Andreas — Chief Innovation Officer
Shares
100,000
Price
$2.29
Total Value
$229.00K
Shares Held After
421,446
% of Holdings
23.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
164
Price
$544.58
Total Value
$89.31K
Shares Held After
130
% of Holdings
55.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
356
Price
$543.22
Total Value
$193.39K
Shares Held After
294
% of Holdings
54.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$542.33
Total Value
$325.40K
Shares Held After
650
% of Holdings
48.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$541.31
Total Value
$216.52K
Shares Held After
1,250
% of Holdings
24.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,240
Price
$539.82
Total Value
$669.37K
Shares Held After
1,650
% of Holdings
42.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
720
Price
$538.94
Total Value
$388.04K
Shares Held After
2,890
% of Holdings
19.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,077
Price
$537.90
Total Value
$579.31K
Shares Held After
3,610
% of Holdings
23.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,772
Price
$536.83
Total Value
$951.27K
Shares Held After
4,687
% of Holdings
27.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,955
Price
$536.02
Total Value
$1.05M
Shares Held After
6,459
% of Holdings
23.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
60
Price
$532.97
Total Value
$31.98K
Shares Held After
8,930
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$532.16
Total Value
$340.58K
Shares Held After
8,990
% of Holdings
6.6%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
5,400
Price
$13.43
Total Value
$72.52K
Shares Held After
512,272
% of Holdings
1.0%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
13,660
Price
$12.63
Total Value
$172.53K
Shares Held After
517,672
% of Holdings
2.6%
Sarepta Therapeutics, Inc. (SRPT)
Mayo Stephen — Director
Shares
7,239
Price
$17.02
Total Value
$123.21K
Shares Held After
1,765
% of Holdings
80.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
300
Price
$85.53
Total Value
$25.66K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
200
Price
$83.38
Total Value
$16.68K
Shares Held After
300
% of Holdings
40.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
3,865
Price
$82.66
Total Value
$319.48K
Shares Held After
500
% of Holdings
88.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
900
Price
$85.53
Total Value
$76.98K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
23,465
Price
$81.75
Total Value
$1.92M
Shares Held After
4,365
% of Holdings
84.3%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
200
Price
$83.38
Total Value
$16.68K
Shares Held After
900
% of Holdings
18.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
CARR EDWARD — CHIEF ACCOUNTING OFFICER
Shares
15,852
Price
$80.71
Total Value
$1.28M
Shares Held After
27,830
% of Holdings
36.3%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
12,796
Price
$82.60
Total Value
$1.06M
Shares Held After
1,100
% of Holdings
92.1%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
65,517
Price
$81.74
Total Value
$5.36M
Shares Held After
13,896
% of Holdings
82.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
43,505
Price
$80.69
Total Value
$3.51M
Shares Held After
79,413
% of Holdings
35.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Randhawa Simrat — EVP, Head of R&D
Shares
33,830
Price
$81.48
Total Value
$2.76M
Shares Held After
0
% of Holdings
100.0%
Crinetics Pharmaceuticals, Inc. (CRNX)
Vivaldi Coelho Rogerio — Director
Shares
523
Price
$36.77
Total Value
$19.23K
Shares Held After
16,300
% of Holdings
3.1%
Crinetics Pharmaceuticals, Inc. (CRNX)
Vivaldi Coelho Rogerio — Director
Shares
4,477
Price
$36.08
Total Value
$161.53K
Shares Held After
16,823
% of Holdings
21.0%
PTC THERAPEUTICS, INC. (PTCT)
Klein Matthew B. — Director
Shares
2,662
Price
$64.08
Total Value
$170.58K
Shares Held After
396,920
% of Holdings
0.7%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
300,000
Price
$5.00
Total Value
$1.50M
Shares Held After
0
% of Holdings
100.0%
ONCOLYTICS BIOTECH INC (ONCY)
Kelly Jared — Director
Shares
5,050
Price
$0.96
Total Value
$4.85K
Shares Held After
114,050
% of Holdings
4.4%
Showing 501–550 of 1341 transactions (page 11 of 27)